Company Filing History:
1 out of 832,812 Years Active: 1991
Title: Alexandr D Koveshinikov: Innovator in Cancer Treatment Technology
Introduction
Alexandr D Koveshinikov is a notable inventor based in Moscow, Russia. He has made significant contributions to the field of medical technology, particularly in the treatment of malignant tumors. His innovative approach combines the use of ferromagnetic particles and electromagnetic fields to target and eliminate cancer cells effectively.
Latest Patents
Koveshinikov holds a patent for a method and apparatus for treating malignant tumors by local hyperpyrexia. This method involves introducing a suspension containing ferromagnetic particles into the body, directing these particles towards a tumor using a magnetic field. The tumor is then exposed to an electromagnetic field, raising its temperature to a level that can kill cancer cells. The patient's condition is monitored throughout the treatment by assessing the activity of neutrophils and macrophages. The apparatus designed for this method includes an electromagnetic radiation source, temperature pickups, and a magnetic retainer to keep the ferromagnetic particles within the tumor's boundaries.
Career Highlights
Throughout his career, Koveshinikov has focused on developing advanced medical technologies that improve patient outcomes. His work in hyperpyrexia treatment represents a significant advancement in cancer therapy, showcasing his commitment to innovation in healthcare.
Collaborations
Koveshinikov has collaborated with notable professionals in his field, including Vasily F Gudov and Nikolai E Yakhontov. These collaborations have contributed to the refinement and implementation of his innovative treatment methods.
Conclusion
Alexandr D Koveshinikov is a pioneering inventor whose work in cancer treatment technology has the potential to transform patient care. His patented method for treating malignant tumors exemplifies the intersection of innovation and healthcare, highlighting the importance of continued research and development in this critical field.